During the past decade, Pines Clinical Research, Inc conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 26 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 15 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pines Clinical Research, Inc" #1 sponsor was "Pfizer" with 10 trials, followed by "Ferring Pharmaceuticals" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Keryx Biopharmaceuticals" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pines Clinical Research, Inc" #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Collaborative Study Group (CSG)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Pines Clinical Research, Inc" are "Uremic Pruritus" (4 trials), "Chronic Kidney Disease" (3 trials), "Pruritus" (3 trials), "Alzheimer Disease" (2 trials) and "Chronic Renal Failure" (2 trials). Many other conditions were trialed in "Pines Clinical Research, Inc" in a lesser frequency.

Most popular intervention types in "Pines Clinical Research, Inc" are "Drug" (34 trials), "Biological" (9 trials), "Other" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Epoetin Hospira" (2 trials), "Mesalamine" (2 trials), "Sevelamer hydrochloride" (2 trials) and "ferric citrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pines Clinical Research, Inc" are 44 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pines Clinical Research, Inc". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Pines Clinical Research, Inc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Pines Clinical Research, Inc, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".